MDR-TB trial 6-month regimen appears effective

A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more patient data was extremely unlikely to change the trial’s outcome. Read about it here.
10 views0 comments

Recent Posts

See All

WHO TB Treatment Outcome Definitions

The World Health Organization (WHO) held an online consultation on the definitions of drug-resistant tuberculosis (DR-TB) treatment outcomes, on 17–19 November 2020. Read the full report here.

TB Molecular Assay Updates—WHO

Significant advances to the diagnosis of tuberculosis (TB) and drug resistance in adults, adolescents and children are expected, following key updates on new molecular assays, announced by the World H